– Kaiser J. Base editing, a new form of gene therapy, sharply lowers bad cholesterol in clinical trial. Science, 2023; doi: 10.1126/science.adm8865.
– Kaiser J. United Kingdom approves first-ever CRISPR treatment, a cure for sickle cell disease and beta thalassemia. Science, 2023; doi: 10.1126/science.adm9989.
Edición del genoma como terapia de hipercolesterolemia, drepanocitosis, talasemia
Filed under Edición del genoma, Medicina personalizada by on . 
You must be logged in to post a comment. Login.
Leave a Comment